The global focus on obesity has never been stronger. This complex condition is now one of the fastest-growing global health challenges, impacting hundreds of millions of people and reshaping the…
Recently, Med Communications had the opportunity to introduce PharmD students at the University of Tennessee College of Pharmacy to medical writing through a one-hour guest lecture. The session kicked off…
Our Scientific Communications team delivers high‑quality, accurate, and compliant scientific content that supports the evolving needs of the pharmaceutical, biotechnology, and healthcare industries. Under the leadership of Liza Rinehart, who…
We’re in Denver at the MAPS 2026 Annual Americas Meeting this week, Booth 116. Business Development Representative Natalie McClendon, Business Development Lead Jill Kembel, Director Scientific Communications and Medical/Promotional Review…
A scientific narrative is a clear, cohesive, memorable, and persuasive story that explains a product’s science from mechanism to patient impact. It connects the unmet need, biology, clinical evidence, and…
Join us in Denver at the MAPS 2026 Annual Americas Meeting, March 22-25. More meeting information is available here: https://s7.goeshow.com/maps/global/2026/. Hope to see you there!
A successful Medical Affairs strategy depends on scientific consistency, operational efficiency, and the ability to scale your team. A comprehensive 360° partner model achieves what fragmented vendors cannot: one team,…
Liza Rinehart, PharmD, is Director, Scientific Communications and Medical/Promotional Review for Med Communications. Liza received her PharmD from the University of Tennessee College of Pharmacy, completed an ASHP-accredited residency, and…
Customer communication in the pharmaceutical industry looks much different than it did just a decade ago. Digital innovations have brought us tools such as interactive standard responses, which offer an…
Managed care organizations and health care decision makers rely on AMCP formulary dossiers when making formulary and medical policy coverage or reimbursement decisions. These dossiers include the most recent, relevant,…
